T cell immune system regulator identified by researchers
A new study has discovered two enzymes which regulate a biological switch that controls the immune system, providing the potential to develop targeted therapies.
List view / Grid view
A new study has discovered two enzymes which regulate a biological switch that controls the immune system, providing the potential to develop targeted therapies.
A new study has linked an inflammatory protein to impaired memory mechanisms which could lead towards finding a more effective treatment for Alzheimer's.
Researchers have polymerised oestrogen using a new approach and found it is effective at protecting and regenerating nervous system cells in vitro.
Researchers have discovered a gene in zebrafish that enables them to successfully recover after cardiac damage, which could be used to repair heart tissues in humans.
A new study has shown the specific cellular mechanisms that limit the ability of CD8 T cells to infiltrate the tumour microenvironment, which could guide new immunotherapeutic strategies in cancer.
A new family of synthetic antibiotics that possess broad anti-Gram-negative antimicrobial activity has been discovered.
A machine-learning algorithm has been created that automates high-throughput screens of epigenetic medicines.
Regulator genes and proteins have been identified on circulating tumour cells in mice which allow them to target other organs in the body.
'Prime editing', a new CRISPR genome-editing approach, is capable of directly editing human cells in an accurate and efficient way.
Researchers have used fullerene compounds to cause NSCLC cell death in cell and animal models, which exhibited low toxicity for healthy cells.
Researchers have discovered a pathway that causes behavioural abnormalities and other hallmarks of autism; they also revealed how to silence this and reverse the symptoms in mice.
Peptide-based nanoparticles have been designed which can suppress pancreatic cancer growth without the toxic side effects.
A new mechanism by which cancer cells become resistant to chemotherapy has been found which could lead to a new target for drugs.
The International Society for Cell and Gene Therapy has created a group to tackle the rising number of commercial cell bank services that are misleading patients.
A new study, which has shown that the congenital heart condition LVNC could be be caused by signalling defects, may lead to potential therapies.